(Q34685526)

3 August 2017

title

Failure to preserve fertility in patients with Hodgkin's disease (English)

1 reference

3 August 2017

0 references

9

G M Besser

1 reference

3 August 2017

J H Waxman

1

1 reference

3 August 2017

R Ahmed

2

1 reference

3 August 2017

D Smith

3

1 reference

3 August 2017

P F Wrigley

4

1 reference

3 August 2017

W Gregory

5

1 reference

3 August 2017

S Shalet

6

1 reference

3 August 2017

D Crowther

7

1 reference

3 August 2017

L H Rees

8

1 reference

3 August 2017

J S Malpas

10

1 reference

3 August 2017

publication date

1 January 1987

1 reference

Cancer Chemotherapy and Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

19

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

159-162

1 reference

Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty

3 August 2017

cites work

1 reference

12 December 2020

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

12 December 2020

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

12 December 2020

Gonadotrophin releasing hormone analogues

1 reference

12 December 2020

Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy

1 reference

12 December 2020

Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist

1 reference

12 December 2020

Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

1 reference

12 December 2020

Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

1 reference

12 December 2020

Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer

1 reference

12 December 2020

Male gonadal dysfunction in Hodgkin's disease. A prospective study

1 reference

12 December 2020

Inhibitory effects on gonadotrophin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue

1 reference

12 December 2020

Gonadal function after combination chemotherapy for Hodgkin's disease in childhood

1 reference

12 December 2020

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

12 December 2020

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

12 December 2020

Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist

1 reference

12 December 2020

Testicular function in boys after chemotherapy for acute lymphoblastic leukemia

1 reference

12 December 2020

Simplified method for measuring sex-hormone binding globulin

1 reference

12 December 2020

Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone

1 reference

12 December 2020

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

12 December 2020

Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254570

1 reference

Dimensions Publication ID

3 August 2017

1012482687

0 references

1 reference